The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).
about
Small activating RNA restores the activity of the tumor suppressor HIC-1 on breast cancerSubcellular localization of MTA proteins in normal and cancer cells.Eph receptors and ephrins as targets for cancer therapy.Loss of Hypermethylated in Cancer 1 (HIC1) in breast cancer cells contributes to stress-induced migration and invasion through β-2 adrenergic receptor (ADRB2) misregulation.Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteinsSignification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression.Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics.HIC1 interacts with and modulates the activity of STAT3.Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinomaHIC1 modulates uveal melanoma progression by activating lncRNA-numb.EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control System.DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (HIC1) by SUMOylation to regulate DNA repair.HIC1 Expression Distinguishes Intestinal Carcinomas Sensitive to Chemotherapy.Functional non-coding polymorphism in an EPHA2 promoter PAX2 binding site modifies expression and alters the MAPK and AKT pathways.Metabolic inflexibility impairs insulin secretion and results in MODY-like diabetes in triple FoxO-deficient mice.The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53.Downregulation of hypermethylated in cancer-1 by - promotes adriamycin resistance in breast cancer cells
P2860
Q28539229-CE32EB8F-AEB1-41D8-BC3D-7BEE7E045387Q34447970-D368C353-266D-4845-A1AD-0ABC99739A2EQ35370195-A4D626D5-BDB5-4F66-B2DB-4FDF5A891E93Q35773945-0D3B5F90-9ADD-41D8-A8B8-99E4B7919839Q35880084-64FABB69-ADF5-4EC1-AD95-343AB882C671Q36284970-1E8B83A2-B576-49C6-9D83-DC322FA98E53Q36545991-315C27FA-8B3A-466C-8AD9-8E9AC695A4B9Q36931136-64CA476F-5F51-4465-A7FE-BFCE11E73667Q37126191-C34113BD-7DC4-456B-B512-46FC97066D05Q37708962-09921B4C-9075-4699-901D-490DD0554694Q38736921-54D834EE-79FD-41D9-8907-66D64F2B4601Q38878649-4BFFE679-B54D-4726-AF6C-EEC2DBC7B5E8Q39794371-6B6E0057-4C94-459A-BD34-388BEF2645CDQ40250355-80813915-989F-444D-81BF-CAE2E7D52561Q41565096-2E8B4EA1-8B94-4F98-950A-3D11D7A4F2A3Q42139800-AA5448A3-76B0-40FF-B94A-EF46ED885FD8Q48171327-E40FF50F-A676-4A33-B678-3DD01D25CBFAQ58765211-D03BB4E0-5E47-4A6F-86EB-60299A0C8052
P2860
The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The receptor tyrosine kinase E ...... methylated in cancer 1 (HIC1).
@ast
The receptor tyrosine kinase E ...... methylated in cancer 1 (HIC1).
@en
type
label
The receptor tyrosine kinase E ...... methylated in cancer 1 (HIC1).
@ast
The receptor tyrosine kinase E ...... methylated in cancer 1 (HIC1).
@en
prefLabel
The receptor tyrosine kinase E ...... methylated in cancer 1 (HIC1).
@ast
The receptor tyrosine kinase E ...... methylated in cancer 1 (HIC1).
@en
P2093
P2860
P356
P1476
The receptor tyrosine kinase E ...... methylated in cancer 1 (HIC1).
@en
P2093
Brian R Rood
Bénédicte Foveau
Gaylor Boulay
Sébastien Pinte
P2860
P304
P356
10.1074/JBC.M111.329466
P407
P577
2011-12-19T00:00:00Z